Clinical Trial Update: A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom [Phase 4]

View source ↗

Summary

Phase 4 trial assessing escitalopram's impact on quality of life and social functioning in adults with major depressive disorder with anxiety symptoms; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED | Results posted: 2016-07-11